ABT
Abbott Laboratories · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +7.5% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 8.65M | $848.35M | n/a | −2 |
| Q2 2026 | 180 | 0 | 1.09B | $98.86B | +5 | −6 |
| Q1 2026 | 184 | +3 | 1.11B | $114.25B | +7 | −5 |
| Q4 2025 | 180 | +2 | 1.17B | $146.24B | +3 | n/a |
| Q3 2025 | 24 | 0 | 623.34M | $83.47B | +1 | −2 |
| Q2 2025 | 22 | 0 | 527.92M | $71.78B | +1 | −1 |
| Q1 2025 | 19 | 0 | 196.20M | $26.01B | +1 | −1 |
| Q4 2024 | 19 | -1 | 182.48M | $20.63B | n/a | −1 |
| Q3 2024 | 19 | 0 | 108.33M | $12.33B | +1 | −1 |
| Q2 2024 | 19 | n/a | 110.87M | $11.51B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 77.66M | +0.6% | $10.30B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 36.90M | +3.5% | $4.88B | 0.4% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 29.76M | +12.8% | $3.95B | 0.8% | ▲ Add | 4 | SEC ↗ ×8 |
| 4 | Norges Bank ✦ (passief) | 21.76M | +3.7% | $2.89B | 0.4% | ▲ Add | 4 | SEC ↗ |
| 5 | Fisher Asset Management ✦ | 11.65M | +3.3% | $1.55B | 0.7% | ▲ Add | 4 | SEC ↗ |
| 6 | Capital World Investors ✦ | 9.01M | +572.8% | $1.19B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 4.17M | +9.9% | $553.22M | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 8 | AQR Capital Management ✦ | 1.72M | +14.9% | $227.12M | 0.2% | ▲ Add | 4 | SEC ↗ ×6 |
| 9 | Adage Capital Partners ✦ | 1.42M | +23.2% | $188.05M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 10 | PRIMECAP Management ✦ | 882.57K | -1.7% | $117.07M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 11 | Millennium Management ✦ | 678.72K | +18.6% | $90.03M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 217.58K | -5.5% | $28.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Marshall Wace ✦ | 156.94K | Nieuw | $20.82M | 0.0% | New | 1 | SEC ↗ ×2 |
| 14 | Bridgewater Associates ✦ | 72.83K | -62.0% | $9.66M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 56.11K | +42.7% | $7.44M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 27.39K | -91.0% | $3.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | GAMCO Investors ✦ | 22.14K | -0.4% | $2.94M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Dodge & Cox ✦ | 17.32K | -3.0% | $2.30M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 17.13K | -41.0% | $2.27M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Marshall Wace | $20.82M | 0.0% |
Verlaten
| Citadel Advisors | $102.14M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 3,058 houders, 1.35B aandelen, $133.47B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 27 aand · $2,958
Officer, Director · 180.30K aand · $20.95M
Officer, Director · 218.53K aand · $25.26M
Officer · 5.85K aand · $642,506
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie